Start with a free account for 3 free CME credits. Already a subscriber? Sign in.

You Can Do It!!

Paperchase 1 - The SWITCH 2 Trial

Andrew Buelt, DO and Joe Weatherly, DO
00:00
08:03
Sign in or subscribe to listen

No me gusta!

The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.

Tags Diabetes · endocrinology · pharmacology

The SWITCH 2 trial compared rates of hypoglycemia in patients with Type 2 DM taking either insulin degludec and or insulin glargine U100.  While degludec treatment was associated with fewer instances of hypoglycemia, Joe and Andrew do not feel it is clinically significant.

 

To view chapter written summaries, you need to subscribe.

Sign up today for full access to all episodes.

To join the conversation, you need to subscribe.

Sign up today for full access to all episodes and to join the conversation.

To download files, you need to subscribe.

Sign up today for full access to all episodes.
You Can Do It!! Full episode audio for MD edition 195:21 min - 92 MB - M4AHippo Peds RAP September 2017 Written Summary 315 KB - PDF